Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Vemurafenib × 30 days × Clear all

Phase

Status

Sponsor Class

OTHER 4 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1

Interventions

Specimen Handling 25 Magnetic Resonance Spectroscopy 23 Cyclophosphamide 15 Vincristine 14 Radiation 13 Biopsy 12 Radiotherapy 11 Etoposide 10 Cisplatin 9 Carboplatin 9 Irinotecan 8 Doxorubicin 8 Cytarabine 8 Leucovorin 7 dehydroftorafur 6 Triptorelin Pamoate 6 Radiotherapy, Intensity-Modulated 6 Platinum 6 Methotrexate 6 Ifosfamide 6 Fluorouracil 6 1,2-diaminocyclohexaneplatinum II citrate 6 X-Rays 5 Taxes 5 Surgical Procedures, Operative 5 Stem Cell Transplantation 5 Standard of Care 5 Spinal Puncture 5 Prednisone 5 Practice Guidelines as Topic 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡